FDA Adverse Event Injury Summary report: N

QIASTAT-DX RESPIRATORY SARS-COV-2 PANEL

MDR report key: 10311876 · Received July 22, 2020

Report

Report Number
3004013603-2020-00004
Event Type
Injury
Date Received
July 22, 2020
Date of Event
June 11, 2020
Report Date
July 22, 2020
Manufacturer
QIAGEN GMBH
Product Code
QJR
PMA / PMN Number
EUA200075
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

NO INJURY WAS REPORTED. QIAGEN IS REPORTING THIS INCIDENT IN AN ABUNDANCE OF CAUTION AND IN ACCORDANCE WITH THE CONDITIONS OF APPROVAL UNDER THE EMERGENCY USE AUTHORIZATION FOR THIS PRODUCT.

Description of Event or Problem · 1

SUSPECTED FALSE POSITIVE RESULTS FOR INFLUENZA A (FLU A) WERE OBTAINED FOR 8 PATIENT SAMPLES BY THE CUSTOMER WITH THE QIASTAT-DX RESPIRATORY SARS-COV-2 PANEL, MAT. 691223.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
775724 QIASTAT-DX RESPIRATORY SARS-COV-2 PANEL REAGENTS, 2019-NOVEL CORONAVIRUS NUCLEIC ACID QJR QIAGEN GMBH 166023368

Patients

Seq Age Sex Outcome Treatment
1 Other